>> 全站文章索引 >> 第33页:
Pindolol potentiation of paroxetine for generalized social phobia: A double-blind, placebo-controlled, crossover study - [Murray B Stein, Jitender Sareen, Shadha Hami, Jeffrey Chao.]
Chronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats - [Miki Yamauchi, Tomoko Tatebayashi, Kinuko Nagase, Maho Kojima and Taiichiro Imanishi]
Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramine - [S. C. Cheetham, J. A. Viggers, N. A. Slater and D. J. Heal]
Evaluation of the neuropharmacodynamics of paroxetine in vivo utilizing microdialysis - [Atulkumar Ramaiya 1, James H. Johnson 2, H. Thomas Karnes 1 * AD:1Department of Pharmacy & Pharmaceutics, Medical College of Virginia/Virginia Commonwealth University, P.O. Box 980533, Richmond, Virginia 23298-980533.2Department of Anatomy, Medical Colleg]
Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia - [Bender S, Weisbrod M, Resch F.]
Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia - [Bender S, Weisbrod M, Resch F.]
Maternal anxiety- course and antecedents during the early postpartum period - [Britton JR.]
Maternal anxiety course and antecedents during the early postpartum period - [Britton JR.]
Drug company experts advised staff to withhold data about SSRI use in children - [Wayne Kondro, Barbara Sibbald]
Treating major depression in primary care practice: An update of the agency for health care policy and research practice guidelines - [Dr. H.C. Schulberg, Western Psychiatric Inst. and Clinic, 3811 O]
Age-Dependent Reductions in the Level of Glial Fibrillary Acidic Protein in the Prefrontal Cortex in Major Depression - [Xiaohong Si, Jose Javier Miguel-Hidalgo, Gillian O]
Multiple Dose Pharmacokinetics of Paroxetine in Children and Adolescents with Major Depressive Disorder or Obsessive–Compulsive Disorder - [Robert L Findling1, Gianluca Nucci2, Antoni A Piergies3, Roberto Gomeni2, Edward I Bartolic4, Regan Fong5, David J Carpenter5, J Steven Leeder6, Andrea Gaedigk6 and Theodore M Danoff5]
Brain kinetics of paroxetine and fluoxetine on the third day of placebo substitution: A fluorine MRS study - [Michael E Henry, Constance M Moore, Marc J Kaufman, David Michelson, et al]
Genetics of suicide - [B Bondy1, A Buettner2 and P Zill1]
Compulsive Voyeurism and Exhibitionism: A Clinical Response to Paroxetine - [Ahmed Abouesh, Anita Clayton]
The clinical response to total sleep deprivation and recovery sleep in geriatric depression: potential indicators of antidepressant treatment outcome - [Cameron R. Hernandez, Gwenn S. Smith, Patricia R. Houck, Bruce G. Pollock, Benoit Mulsant, Mary Amanda Dew and Charles F. Reynolds III]
Effect of a selective 5-hydroxytryptamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetine - [éva Hajós-Korcsok, Sarah F. B. McTavish and Trevor Sharp]
PLASMA MEMBRANE MONOAMINE TRANSPORTERS: STRUCTURE, REGULATION AND FUNCTION - [Gonzalo E. Torres, Raul R. Gainetdinov & Marc G. Caron about the authors]
Enantiomeric analysis of (3S,4R)-4-(4-fluorophenyl)- 3-hydroxymethyl-1-methylpiperidine by 19F NMR spectroscopy - [Hana Navrátilová * AD:Department of Organic Chemistry, Faculty of Science, Masaryk University, 611 37 Brno, Czech Republic]
The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression - [A Szegedi1, D Rujescu2, A Tadic3, M J Müller3, R Kohnen4, H H Stassen5 and N Dahmen3]
Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder - [Strawn JR, Geracioti TD]
Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder - [Strawn JR, Geracioti TD.]
Chronic schizophrenia: Response to clozapine, risperidone, and paroxetine - [Jayendra K Patel, Carl Salzman, Alan I Green, Ming T Tsuang]
UK bans,Health Canada warns about antidepressants - [Barbara Sibbald]
Cardiovascular Side Effects of New Antidepressants and Antipsychotics: New Drugs, old Concerns? - [Pal Pacher, Valeria Kecskemeti]
Evidence-based guidelines for treating bipolar disorder-recommendations from the British Association for Psychopharmacology - [Goodwin GM; Consensus Group of the British Association for Psychopharmacology.]
Comparative Affinity of Duloxetine and Venlafaxine for Serotonin and Norepinephrine Transporters in vitro and in vivo, Human Serotonin Receptor Subtypes, and Other Neuronal Receptors - [Bymaster FP, Dreshfield-Ahmad LJ, Threlkeld PG, Shaw JL, Thompson L, Nelson DL, Hemrick-Luecke SK, Wong DT.]
O- and N-demethylation of Venlafaxine In Vitro by Human Liver Microsomes and by Microsomes from cDNA-Transfected Cells: Effect of Metabolic Inhibitors and SSRI Antidepressants - [Steven M Fogelman, Jürgen Schmider, Karthik Venkatakrishnan, Lisa L von Moltke, Jerold S Harmatz, Richard I Shader and David J Greenblatt]
KNOCKOUTS MODEL THE 100 BEST-SELLING DRUGS—WILL THEY MODEL THE NEXT 100? - [Brian P. Zambrowicz & Arthur T. Sands about the authors]
Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood - [Gunther H. Moll, Claas Mehnert, Maike Wicker, Nathalie Bock, Aribert Rothenberger, Eckart Rüther and Gerald Huether]
Is the Platelet Serotonin Transporter Different in Venous vs. Arterial Blood - [Villa E, Albano C, Cappelli A, Favale E, Fugassa E, Gerdoni E, Scarrone S, Cupello A.]
Regional distribution of specific high affinity binding sites for 3H-imipramine and 3H-paroxetine in human brain - [P. Rosel, J. M. Menchon, M. Oros, J. Vallejo, T. Cortadellas, B. Arranz, P. Alvarez, M. A. Navarro]
Depression and somatic symptoms scale A new scale with both depression and somatic symptoms emphasized - [Hung CI, Weng LJ, Su YJ, Liu CY.]
Body pain and treatment response in late-life depression. - [Karp JF, Weiner D, Seligman K, Butters M, Miller M, Frank E, Stack J, Mulsant BH, Pollock B, Dew MA, Kupfer DJ, Reynolds CF 3rd]
The impact of CYP2D6 genotypes on the plasma concentration of paroxetine in Japanese psychiatric patients - [Mikito Ueda, Genta Hirokane, Sachiyo Morita, Masako Okawa, Takashi Watanabe, Kazufumi Akiyama and Kazutaka Shimoda]
Unusual manifestations of premenstrual syndrome - [Hsiao MC, Liu CY.]
Weight change in older depressed patients during acute pharmacotherapy with paroxetine and nortriptyline - [Elizabeth Weber, Jacqueline Stack, Bruce G Pollock, Benoit Mulsant, et al.]
Generalized Anxiety and Depression: Assessment Over 2 Years After Stroke - [Schultz, Susan K.; Castillo, Carlos S.; Kosier, J. Todd; Robinson, Robert G.]
Selective Serotonin Reuptake Inhibitor Usage Patterns as Risk Factors for Hospitalization - [Reinee E. Sheffield, Anthony T. Lo Sasso, Christopher H. Young, Karen Way]
Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteers - [Patricia M Furlan, Michael J Kallan, Thomas Ten Have, Bruce G Pollock, et al.]
Which SSRI? A Meta-Analysis of Pharmacotherapy Trials in Pediatric Obsessive-Compulsive Disorder. - [Geller DA, Biederman J, Stewart SE, Mullin B, Martin A, Spencer T, Faraone SV]
Enantioselective synthesis of 3-substituted-4-aryl piperidines useful for the preparation of paroxetine - [K. S. Keshava Murthy, Allan W. Rey and Michael Tjepkema]
Disseminated pilocytic astrocytoma involving brain stem and diencephalon a history of atypical eating disorder and diagnostic delay - [Distelmaier F, Janssen G, Mayatepek E, Schaper J, G?bel U, Rosenbaum T.]
Assessment of Depression in Patients With Brain Pathology: The Case of Stroke - [Spencer, Kristie A.; Tompkins, Connie A.; Schulz, Richard]
Novel treatment approaches for refractory anxiety disorders - [Pollack MH, Otto MW, Roy-Byrne PP, Coplan JD, Rothbaum BO, Simon NM, Gorman JM.]
Effect of prolonged exposure to milnacipran on norepinephrine transporter in cultured bovine adrenal medullary cells - [Koji Shinkai, Reiji Yoshimura, Yumiko Toyohira, Susumu Ueno, Masato Tsutsui, Jun Nakamura and Nobuyuki Yanagihara]
Clinical Neurochemical Implications of Sleep Deprivation's Effects on the Anterior Cingulate of Depressed Responders - [Joseph C Wu1 MD, Monte Buchsbaum2 MD and William E Bunney Jr1 MD]
Amygdala Volume Reductions in Pediatric Patients with Obsessive-Compulsive Disorder Treated with Paroxetine: Preliminary Findings - [Philip R Szeszko1,2, Shauna MacMillan3, Marjorie McMeniman1,2, Elisa Lorch3, Rachel Madden3, Jennifer Ivey3, S Preeya Banerjee3, Gregory J Moore3,4 and David R Rosenberg3,5]
Paroxetine during breast-feeding: infant weight gain and maternal adherence to counsel - [Paul Merlob, Bracha Stahl, Jaqueline Sulkes]
Serotonergic markers and lowered plasma branched-chain-amino acid concentrations in fibromyalgia - [Michael Maes, Robert Verkerk, Laure Delmeire, Ann Van Gastel, Fran van Hunsel and Simon Scharpé]
Relation between depression after stroke, antidepressant therapy, and functional recovery - [Gainotti, G.; Antonucci, G.; Marra, C.; Paolucci, S.]
Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis - [M D Waldinger, A H Zwinderman, D H Schweitzer, B Olivier]
Impact of chronic graft-versus-host disease on the health status of hematopoietic - [Fraser CJ, Bhatia S, Ness K, Carter A, Francisco L, Arora M, Parker P, Forman S, Weisdorf D, Gurney JG, Baker KS.]
Evaluation of Suicidal Thoughts and Behaviors in Children and Adolescents Taking Paroxetine - [Alan Apter, Alan Lipschitz, Regan Fong, David J. Carpenter, Stan Krulewicz, John T. Davies, Christel Wilkinson, Philip]
Serotonin transporter gene regulatory region polymorphism (5-HTTLPR), [3H]-paroxetine binding in healthy controls and alcohol dependants and its relation to impulsivity - [U. W. Preuss, M. Soyka, M. Bahlmann, K. Wenzel, S. Behrens, S. De Jonge, M. Krüger and B. Bondy 449.]
Serotonin transporter gene regulatory region polymorphism (5-HTTLPR), [3H]paroxetine binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity - [Ulrich W. Preuss, Michael Soyka, Miriam Bahlmann, Karin Wenzel, Stefanie Behrens, Sylvia de Jonge, Marc Krüger and Brigitta Bondy]
Multiple 5-HT Receptors in Passive Avoidance: Comparative Studies of p-Chloroamphetamine and 8-OH-DPAT - [Ilga Misane Ph.D, Sven Ove ?gren and Med Sc]
Fatty acids differentially affect serotonin receptor and transporter binding in the rat brain - [T.M. du Bois, C. Deng, W. Bell and X.-F. Huang]
An International, Multicenter, Placebo-Controlled Trial of Paroxetine in Adolescents with Major Depressive Disorder - [Ray Berard, Regan Fong, David J. Carpenter, Christine Thomason, Christel Wilkinson]
CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline - [Alfaro, Cara L. PharmD; Lam, Y. W. Francis PharmD; Simpson, Joseph MD; Ereshefsky, Larry PharmD]
The seizure outcome after amygdalohippocampectomy and temporal lobectomy - [Bate H, Eldridge P, Varma T, Wieshmann UC.]
Post-Stroke Depression, Antidepressant Treatment and Rehabilitation Results - [Stefano Paolucci, Gabriella Antonucci, Maria Grazia Grasso, Daniela Morelli, Elio Troisi, Paola Coiro, Domenico De Angelis, Francesco Rizzi, Maura Bragoni]
Mirtazapine Versus Venlafaxine in Hospitalized Severely Depressed Patients With Melancholic Features - [Guelfi JD, Ansseau M, Timmerman L, K?rsgaard S; Mirtazapine-Venlafaxine Study Group.]
Postmarketing Surveillance of Suicidal Adverse Events with Pediatric Use of Antidepressants - [Andrew D. Mosholder, Carol A. Pamer]
Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects - [A. Gerdelat-Mas, I. Loubinoux, D. Tombari, O. Rascol, F. Chollet and M. Simonetta-Moreau]
5-HT2A receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study - [Cristina Messa, Cristina Colombo, Rosa Maria Moresco, Clara Gobbo, Laura Galli, Giovanni Lucignani, Maria Carla]
SSRIs antidepressant activity is influenced by Gβ3 variants - [Alessandro Serretti, Cristina Lorenzi, Cristina Cusin, Raffaella Zanardi, Enrico Lattuada, David Rossini, Roberta Lilli, Adele Pirovano, Marco Catalano and Enrico Smeraldi]
Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity - [A Serretti, R Zanardi, D Rossini, C Cusin, R Lilli and E Smeraldi]
Olanzapine augmentation of paroxetine-refractory obsessive-compulsive disorder - [Giuseppina D]
Participation of the 5-HT1A Receptor in the Antidepressant-Like Effect of Estrogens in the Forced Swimming Test - [Erika Estrada-Camarena1, Alonso Fernández-Guasti2 and Carolina López-Rubalcava2]
Different distributions of the 5-HT reuptake complex and the postsynaptic 5-HT2A receptors in Brodmann areas and brain hemispheres - [Pilar Rosel, Belén Arranz, Mikel Urretavizcaya, Miguel Oros, Luis San, Julio Vallejo and Miguel Angel Navarro]
The effects of paroxetine on rat isolated vas deferens - [Ersin Yaris, Murat Kesim, Mine Kadioglu, Nuri Ihsan Kalyoncu, Cunay Ulku and Rasin Ozyavuz]
The relationship between cognitive dysfunction and stress sensitivity in schizophrenia A replication study - [Morrens M, Krabbendam L, Bak M, Delespaul P, Mengelers R, Sabbe B, Hulstijn W, van Os J, Myin-Germeys I.]
The Serotonin Reuptake Inhibitor Fluoxetine Reduces Sex Steroid-Related Aggression in Female Rats: An Animal Model of Premenstrual Irritability? - [Hoi-Por Ho MS, Marie Olsson, M Pharm, Lars Westberg BS, Jonas Melke MS and Elias Eriksson Ph.D]
Management of AIDS-related Kaposi’s sarcoma - [Di Lorenzo G, Konstantinopoulos PA, Pantanowitz L, Di Trolio R, De Placido S, Dezube BJ.]
The Selective 5-HT2A Receptor Antagonist M100907 Enhances Antidepressant-Like Behavioral Effects of the SSRI Fluoxetine - [Gerard J Marek1, Raul Martin-Ruiz2, Allyson Abo1 and Francesc Artigas2]
Partial lesion of the serotonergic system by a single dose of MDMA results in behavioural disinhibition and enhances acute MDMA-induced social behaviour on the social interaction test - [Romeo D. Ando, Anita Benko, Linda Ferrington, Eszter Kirilly, Paul A.T. Kelly and Gyorgy Bagdy]
Mice lacking the norepinephrine transporter are supersensitive to psychostimulants - [Fei Xu, Raul R. Gainetdinov, William C. Wetsel, Sara R. Jones, Laura M. Bohn, Gary W. Miller, Yan-Min Wang, Marc G. Caron]
In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice - [J F Cryan1 and C Mombereau1]
Hallmarks of telomeres in ageing research - [Shay JW, Wright WE.]
Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation. - [van Geffen EC, Hugtenburg JG, Heerdink ER, van Hulten RP, Egberts AC]
The Effect of Paroxetine on Taijinkyofusho:A Report of Three Cases - [.]
Paroxetine may help with hot flushes - [Anonymous]
Major depressive disorders: clinical efficacy and tolerability of agomelatine, a new melatonergic agonist - [Stuart A. Montgomery]
Post-Stroke Depression: Relationships to Functional Impairment, Coping Strategies, and Rehabilitation Outcome - [SINYOR, D. AVID; AMATO, P. HYLLIS; KALOUPEK, D. ANNY; BECKER, R. UBIN; GOLDENBERG, M. ARVIN; COOPERSMITH, H. ENRY]
Lesion Location and Depression in Hospitalized Stroke Patients - [Morris, Philip L.; Robinson, Robert G.; Raphael, Beverley M.]
ECT for Post-stroke Depression: Beta Blockade to Modify Rise in Blood Pressure - [Allman, Peter M.; Hawton, Keith D.]
Serotonin Transporter: A Potential Substrate in the Biology of Suicide - [David C Purselle and Charles B Nemeroff]
Serotonin 1A Receptors, Serotonin Transporter Binding and Serotonin Transporter mRNA Expression in the Brainstem of Depressed Suicide Victims - [Victoria Arango1,2,3 Ph.D, Mark D Underwood1,2 Ph.D, Maura Boldrini1,2 MD, Hadassah Tamir1,2,3 Ph.D, Suham A Kassir1 BA, Shu-chi Hsiung1 MS, Jason J-X Chen3 MD, Ph.D and J John Mann1,2 MD]
Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test - [F. Chenu, B.P. Guiard, M. Bourin and A.M. Gardier]
Sleep Disturbances in Patients with Post-Traumatic Stress Disorder Epidemiology, Impact and Approaches to Management - [Maher MJ, Rego SA, Asnis GM.]
Depressive Symptoms and Adherence to Asthma Therapy After Hospital Discharge - [Smith A, Krishnan JA, Bilderback A, Riekert KA, Rand CS, Bartlett SJ.]
Micturition syncope following intermittent catheterisation in a tetraplegic patient - [Previnaire JG, Soler JM.]
Correlation of subjective and objective sleep measurements at different stages of the treatment of depression - [Spilios V. Argyropoulos, Jane A. Hicks, Jon R. Nash, Caroline J. Bell, Ann S. Rich, David J. Nutt and Susan J. Wilson]
Implications of compulsive and impulsive traits for serotonin status in women with bulimia nervosa - [Howard Steiger, Mimi Isra?l, Lise Gauvin, N. M. K. Ng Ying Kin and Simon N. Young]
Phenylpiperidine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureus - [Glenn W. Kaatz, Varsha V. Moudgal, Susan M. Seo, John Bondo Hansen and Jette E. Kristiansen]
Effects of Standardized Extracts of St. John's Wort on the Single-Unit Activity of Serotonergic Dorsal Raphe Neurons in Awake Cats: Comparisons with Fluoxetine and Sertraline - [Casimir A Fornal Ph.D, Christine W Metzler MS, Christian Mirescu BS, Susan K Stein MS and Barry L Jacobs Ph.D]
The effects of St. John's Wort (Hypericum perforatum) on NK cell activity in vitro - [C. M. Helgason, J. L. Wieseler Frank, D. R. Johnson, M. G. Frank and S. E. Hendricks]
Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer - [Isabelle Loubinoux, David Tombari, Jérémie Pariente, Angélique Gerdelat-Mas, Xavier Franceries, Emmanuelle Cassol, Olivier Rascol, Josette Pastor and Fran?ois Chollet]
SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. I: Neurochemical and Electrophysiological Profile - [Yves Claustre1, Danielle De Peretti1, Philippe Brun3, Christiane Gueudet2, Nathalie Allouard1, Richard Alonso2, Jo?lle Lourdelet1, André Oblin1, Gabrielle Damoiseau1, Dominique Fran?on1, Marie-Fran?oise Suaud-Chagny3, Régis Steinberg2, Mireille Sevrin1, H]
分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 [33] 34 35 36 37 38 39 40
41 42 43 44 45 46 47 48 49 50 |